Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
iBio Inc. announced research results showing that a single administration of the candidate drug IBIO-610 in an obese non-human primate model achieved nearly complete inhibition of active activin E for up to eight weeks.

iBio Inc. announced research results showing that a single administration of the candidate drug IBIO-610 in an obese non-human primate model achieved nearly complete inhibition of active activin E for up to eight weeks.

老虎证券老虎证券2026/07/01 11:21
Show original
This data reveals that the therapy exhibits lasting pharmacological activity in targeting this specific pathway.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Three giants join forces: Qualcomm (QCOM.US), Lumentum (LITE.US), and Corning (GLW.US) showcase optical interconnect, targeting AI horizontal scaling architecture

Qualcomm, Lumentum, and Corning will jointly demonstrate a high-density optical D2D architecture for AI, targeting CPO and UCIe.

智通财经2026/09/21 11:26